SYNAPTICS Inc
For the period ended Sep 28, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 28, 2024 · Filed Nov 7, 2024
SYNA$117.25+0.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Table of Contents
SYNAPTICS INCORPORATED
QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTER ENDED SEPTEMBER 28, 2024
TABLE OF CONTENTS
| Page | ||
|---|---|---|
| Part I. Financial Information | ||
| Item 1. · Condensed Consolidated Financial Statements (Unaudited): | ||
| Condensed Consolidated Balance Sheets—September 28, 2024 and June 24, 2023 | 3 | |
| Condensed Consolidated Statements of Operations—Three Months Ended September 28, 2024 and September 30, 2023 | 4 | |
| Condensed Consolidated Statements of Comprehensive Loss—Three Months Ended September 28, 2024 and September 30, 2023 | 5 | |
| Condensed Consolidated Statements of Stockholders’ Equity—Three Months Ended September 28, 2024 and September 30, 2023 | 6 | |
| Condensed Consolidated Statements of Cash Flows—Three Months Ended September 28, 2024 and September 30, 2023 | 8 | |
| Notes to Condensed Consolidated Financial Statements | 9 | |
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 24 |
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 31 |
| Item 4. | Controls and Procedures | 31 |
| Part II. Other Information | ||
| Item 1. | Legal Proceedings | 32 |
| Item 1A. | Risk Factors | 32 |
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 33 |
| Item 6. | Exhibits | 34 |
| Signatures | 35 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.